SCHEMBL11371

SCHEMBL11371

C=C1CCC2(CC1)CCN(c1ccc(CC(F)(F)F)cc1)C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.34
USP2 O75604 6/20 0.33
CYP3A4 P08684 6/20 0.33
CYP2D6 P10635 5/20 0.33
ALDH1A1 P00352 4/20 0.33
CYP1A2 P05177 3/20 0.33
CYP2C19 P33261 3/20 0.33
TP53 P04637 2/20 0.33
HPGD P15428 2/20 0.33
MAPK1 P28482 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HSD17B10 Q99714 2/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
LIPE Q05469 1/20 0.32
ITGB3 P05106 2/20 0.32
ITGA2B P08514 2/20 0.32
TSHR P16473 3/20 0.32
CYP2C9 P11712 2/20 0.32
RORC P51449 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5578 0.78 LIPE (0.34) USP2CYP3A4ALDH1A1CYP1A2CYP2C19
SCHEMBL746750 0.74 CYP3A4 (0.44) USP2CYP3A4CYP2D6ALDH1A1CYP1A2
SCHEMBL1589633 0.71 LIPE (0.46) LIPE
SCHEMBL22466178 0.66 ALDH1A1 (0.48) USP2CYP3A4CYP2D6ALDH1A1CYP1A2
SCHEMBL30330141 0.65 ADRB1 (0.52) USP2ALDH1A1HSD17B10TSHR
SCHEMBL364099 0.65 SLC6A2 (0.44) USP2CYP3A4CYP2D6ALDH1A1CYP1A2
SCHEMBL747930 0.64 LIPE (0.44) USP2CYP3A4CYP2D6ALDH1A1CYP1A2
SCHEMBL18357721 0.63 CHRM4 (0.41) KCNH2ALDH1A1TSHR
SCHEMBL20345536 0.63 CHRM4 (0.41) KCNH2ALDH1A1TSHR
SCHEMBL7670360 0.61 ESR1 (0.38) CYP3A4ALDH1A1CYP1A2CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed